Search Results - "Mototsugu Shimokawa"

Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer by Matsubara, Taichi, Takamori, Shinkichi, Haratake, Naoki, Fujishita, Takatoshi, Toyozawa, Ryo, Ito, Kensaku, Shimokawa, Mototsugu, Yamaguchi, Masafumi, Seto, Takashi, Okamoto, Tatsuro

“…Background Three immune-nutritional parameters exist for malignant tumors using serum C-reactive protein (CRP) and albumin: the Glasgow prognostic score (GPS),…”
Get full text

Clinical Significance of PD-L1 Protein Expression in Surgically Resected Primary Lung Adenocarcinoma by Takada, Kazuki, Okamoto, Tatsuro, Shoji, Fumihiro, Shimokawa, Mototsugu, Akamine, Takaki, Takamori, Shinkichi, Katsura, Masakazu, Suzuki, Yuzo, Fujishita, Takatoshi, Toyokawa, Gouji, Morodomi, Yosuke, Okano, Shinji, Oda, Yoshinao, Maehara, Yoshihiko

“…The clinicopathological features of carcinomas expressing programmed death ligand 1 (PD-L1) and their associations with common driver mutations, such as…”
Get more information

Tofogliflozin decreases body fat mass and improves peripheral insulin resistance by Matsuba, Ren, Matsuba, Ikuro, Shimokawa, Mototsugu, Nagai, Yoshio, Tanaka, Yasushi

“…The impact of tofogliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on peripheral glucose uptake in patients with type 2 diabetes mellitus (T2DM) was…”
Get full text

Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan by Tamura, Kazuo, Aiba, Keisuke, Saeki, Toshiaki, Nakanishi, Yoichi, Kamura, Toshiharu, Baba, Hideo, Yoshida, Kazuhiro, Yamamoto, Nobuyuki, Kitagawa, Yuko, Maehara, Yoshihiko, Shimokawa, Mototsugu, Hirata, Koichi, Kitajima, Masaki

“…Background Many cancer patients suffer from the common side effect of chemotherapy-induced nausea and vomiting (CINV). Guidelines recommend a combination of…”
Get full text

Interleukin-38 promotes tumor growth through regulation of CD8+ tumor-infiltrating lymphocytes in lung cancer tumor microenvironment by Kinoshita, Fumihiko, Tagawa, Tetsuzo, Akamine, Takaki, Takada, Kazuki, Yamada, Yuichi, Oku, Yuka, Kosai, Keisuke, Ono, Yuki, Tanaka, Kensuke, Wakasu, Sho, Oba, Taro, Osoegawa, Atsushi, Shimokawa, Mototsugu, Oda, Yoshinao, Hoshino, Tomoaki, Mori, Masaki

“…Background Interleukin (IL)-38 was discovered in 2001 and is a member of the IL-1 family of cytokines. IL-38 shows anti-inflammatory activity in several…”
Get full text

Comparison of Inflammation-Based Prognostic Scores Associated with the Prognostic Impact of Adenocarcinoma of Esophagogastric Junction and Upper Gastric Cancer by Kudou, Kensuke, Nakashima, Yuichiro, Haruta, Yasuhiro, Nambara, Sho, Tsuda, Yasuo, Kusumoto, Eiji, Ando, Koji, Kimura, Yasue, Hashimoto, Kenkichi, Yoshinaga, Keiji, Saeki, Hiroshi, Oki, Eiji, Sakaguchi, Yoshihisa, Kusumoto, Tetsuya, Ikejiri, Koji, Shimokawa, Mototsugu, Mori, Masaki

“…Background Several inflammation-based prognostic scores have a prognostic value in patients with various cancers. This study investigated the prognostic value…”
Get full text

More subtle microsatellite instability better predicts fluorouracil insensitivity in colorectal cancer patients by Miyashita, Kaname, Shioi, Seijiro, Kajitani, Tatsuhiro, Koi, Yumiko, Shimokawa, Mototsugu, Makiyama, Akitaka, Oda, Shinya, Esaki, Taito

“…Microsatellite instability (MSI) is now widely used as an indispensable biomarker. However, the relationship between MSI-H (high) and defective DNA mismatch…”
Get full text

Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma by Kinoshita, Fumihiko, Takada, Kazuki, Yamada, Yuichi, Oku, Yuka, Kosai, Keisuke, Ono, Yuki, Tanaka, Kensuke, Wakasu, Sho, Oba, Taro, Osoegawa, Atsushi, Tagawa, Tetsuzo, Shimokawa, Mototsugu, Oda, Yoshinao, Mori, Masaki

“…Background Immunotherapy has become a standard treatment option for non-small cell lung cancer (NSCLC), with the tumor microenvironment attracting significant…”
Get full text

A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin‐Based Chemotherapy‐Induced Nausea and Vomiting in Japan by Iihara, Hirotoshi, Shimokawa, Mototsugu, Hayashi, Toshinobu, Kawazoe, Hitoshi, Saeki, Toshiaki, Aiba, Keisuke, Tamura, Kazuo

“…Background We previously reported the results of a prospective study of chemotherapy‐induced nausea and vomiting (CINV) in a cohort of patients who received…”
Get full text

Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis by Hayashi, Toshinobu, Shimokawa, Mototsugu, Matsuo, Koichi, Iihara, Hirotoshi, Kawada, Kei, Nakano, Takafumi, Egawa, Takashi

“…Patients with lung cancer who are treated with carboplatin-based chemotherapy regimens often experience chemotherapy-induced nausea and vomiting (CINV)…”
Get full text

Efficacy of one-day versus multiple-day dexamethasone for chemotherapy-induced nausea and vomiting in lung cancer patients receiving carboplatin-based chemotherapy: a propensity score–matched analysis by Hayashi, Toshinobu, Shimokawa, Mototsugu, Mizuki, Fumitaka, Matsuo, Koichi, Kawada, Kei, Nakano, Takafumi, Egawa, Takashi

“…Purpose Dexamethasone (DEX)-sparing strategies (one-day DEX) with palonosetron as doublet antiemetic prophylaxis have previously been studied. However,…”
Get full text

Comments on “Lobe-specific Lymph Node Dissection in Clinical Stage IA Solid-dominant Non-small-cell Lung Cancer: A Propensity Score Matching Study” by Takamori, Shinkichi, Takada, Kazuki, Shimokawa, Mototsugu, Okamoto, Tatsuro

“…•In patients with early-stage non-small-cell lung cancer (NSCLC) patients who undergo curative lung resection, the required extent of thoracic lymphadenectomy…”
Get full text

Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma by Yamamoto, Yoshiaki, Yatsuda, Junji, Shimokawa, Mototsugu, Fuji, Nakanori, Aoki, Akihiko, Sakano, Shigeru, Yamamoto, Mitsutaka, Suga, Akinobu, Tei, Yasuhide, Yoshihiro, Satoru, Kitahara, Seiji, Nagao, Kazuhiro, Takai, Kimio, Kamiryo, Yoriaki, Akao, Jumpei, Yamaguchi, Shiro, Oba, Kazuo, Shimabukuro, Tomoyuki, Matsumoto, Hiroaki, Kamba, Tomomi, Matsuyama, Hideyasu

“…Background Pembrolizumab is effective in a limited number of patients with advanced urothelial carcinoma (UC). Therefore, we evaluated the prognostic value of…”
Get full text

Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors by Takada, Kazuki, Yoneshima, Yasuto, Tanaka, Kentaro, Okamoto, Isamu, Shimokawa, Mototsugu, Wakasu, Sho, Takamori, Shinkichi, Toyokawa, Gouji, Oba, Taro, Osoegawa, Atsushi, Tagawa, Tetsuzo, Oda, Yoshinao, Nakanishi, Yoichi, Mori, Masaki

“…Purpose The aim of this study was to elucidate the clinical impact of skeletal muscle area (SMA) in patients with non-small cell lung cancer (NSCLC) treated…”
Get full text

5HT3RA plus dexamethasone plus aprepitant for controlling delayed chemotherapy‐induced nausea and vomiting in colorectal cancer by Hayashi, Toshinobu, Shimokawa, Mototsugu, Matsuo, Koichi, Nishimura, Junichi, Iihara, Hirotoshi, Nakano, Takafumi, Egawa, Takashi

“…Delayed chemotherapy‐induced nausea and vomiting (CINV) is not well controlled in colorectal cancer (CRC) patients undergoing oxaliplatin (L‐OHP)‐based…”
Get full text

Precision length determination and in silico simulation in PCR of microsatellite repeat sequences by Shioi, Seijiro, Shimamoto, Akiyoshi, Nakagami, Yuki, Qin, Lexin, Shimokawa, Mototsugu, Oda, Shinya

“…Despite being commonplace, polymerase chain reactions (PCRs) still contain many unknown aspects. One example is microsatellite PCR, which is now widely used…”
Get full text

Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapy by Takada, Kazuki, Kohashi, Kenichi, Shimokawa, Mototsugu, Haro, Akira, Osoegawa, Atsushi, Tagawa, Tetsuzo, Seto, Takashi, Oda, Yoshinao, Maehara, Yoshihiko

“…•We examined the clinical significance of IDO1/PD-L1 co-expression in lung SCC.•IDO1 expression was significantly associated with PD-L1 expression.•IDO1/PD-L1…”
Get full text

PD-L1 expression according to the EGFR status in primary lung adenocarcinoma by Takada, Kazuki, Toyokawa, Gouji, Tagawa, Tetsuzo, Kohashi, Kenichi, Shimokawa, Mototsugu, Akamine, Takaki, Takamori, Shinkichi, Hirai, Fumihiko, Shoji, Fumihiro, Okamoto, Tatsuro, Oda, Yoshinao, Maehara, Yoshihiko

“…•Association between PD-L1 expression and EGFR mutation site is poorly reported.•We investigated the association between PD-L1 expression and EGFR…”
Get full text

Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan by Ikoma, Tatsuki, Shimokawa, Mototsugu, Kotaka, Masahito, Matsumoto, Toshihiko, Nagai, Hiroki, Boku, Shogen, Shibata, Nobuhiro, Yasui, Hisateru, Satake, Hironaga

“…RAS/BRAF mutations are the most remarkable oncogenic driver mutations in colorectal cancer (CRC) and play an important role in treatment selection. No data are…”
Get full text

A Positive Correlation Between the EZH2 and PD-L1 Expression in Resected Lung Adenocarcinomas by Toyokawa, Gouji, Takada, Kazuki, Tagawa, Tetsuzo, Hamamoto, Ryuji, Yamada, Yuichi, Shimokawa, Mototsugu, Oda, Yoshinao, Maehara, Yoshihiko

“…Enhancer of zeste homolog 2 (EZH2) is reported to be involved in lung cancer pathogenesis via the epigenetic regulation of various genes. Recently, EZH2 was…”
Get full text